➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Harvard Business School
Mallinckrodt
Baxter
Johnson and Johnson

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

Claims for Patent: 6,879,916

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,879,916
Title: Data processing of the maize prolifera genetic sequence
Abstract:The invention provides isolated prolifera nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering prolifera levels in plants. The invention further provides recombinant expression cassettes, host cells, transgenic plants, and antibody compositions.
Inventor(s): Nadimpalli; Ramgopal (Bloomfield, NJ), Simmons; Carl R. (Des Moines, IA)
Assignee: Pioneer Hi-Bred International, Inc. (Des Moines, IA)
Application Number:10/101,080
Patent Claims:1. A data processing system, comprising: data representing at least one genetic sequence in a memory of said data processing system, wherein said genetic sequence is: (i) a polynucleotide of at least 1500 contiguous nucleotides in length with at least 90% sequence identity to a polynucleotide sequence of SEQ ID NO: 1, or (ii) a polypeptide of at least 550 contiguous amino acids In length with at least 90% sequence identity to the polypeptide sequence of SEQ ID NO: 2, wherein sequence identity is calculated according to the method of the GAP program under default parameters; a genetic identification, analysis, or modeling computer program designed to govern the processing of said data; and a data processor having an output for storing or displaying data processing results, said data processor containing said data and said computer program and executing instructions according to said computer program to process said data or a contiguous subsequence thereof.

2. The data processing system of claim 1, wherein said data processing system is a distributed system having its input and output portions separated from at least some of its processing portions.

3. The data processing system of claim 2, wherein said data processing is distributed over an intranet, an internet, or both.

4. The data processing system of claim 1, wherein said program comprises at least one of: a sequence similarity calculation application, a sequence identity calculation application, a protein structure determination application, a sequence alignment determination application, a translation application, a backtranslation application, an antigenicity identification application, a secondary structure identification application, a hydrophobicity calculation application, an isoelectric point calculation application.

5. The data processing system of claim 1, wherein said data processor stores said data in a memory while processing said data, and wherein successive portions of said data are copied sequentially into at least one register of said data processor where said portions are processed.

6. The data processing system of claim 1, wherein said genetic sequence is a test sequence input into said memory from a gene or protein database.

7. The data processing system of claim 1, wherein said genetic sequence is a reference sequence.

8. The data processing system of claim 1, wherein said computer program is a genetic identification computer program.

9. The data processing system of claim 1, wherein said genetic sequence is: (i) a palynucleotide of at least 1800 contiguous nucleotides in length with at least 95% sequence identity to a polynucleotide sequence of SEQ ID NO:1, or (ii) a polypeptide of at least 600 contiguous amino acids in length with at least 95% sequence identity to a polypepilde sequence of SEQ ID NO:2.

10. A data processing system having a memory and enabling programs to process data contained in said memory, comprising: at least one data structure in said memory, said data structure supporting computer program access to data representing the genetic sequence, wherein said genetic sequence is: (i) a polynucleotide of at least 1500 contiguous nucleotides in length with at least 90% sequence identity to the polynucleotide sequence of SEQ ID NO: 1, or (ii) a polypeptide of at least 550 contiguous amino acids in length with at least 90% sequence identity to a polypeptide sequence of SEQ ID NO: 2, wherein sequence identity is calculated according to the method of the GAP program under default parameters; and at least one genetic identification, analysis, or modeling computer program in said memory, said computer program directing the execution of instructions by said data processing system and using said genetic sequence to identify, analyze, or model at least one data element corresponding to a logical subcomponent of said genetic sequence.

11. The data processing system of claim 10, wherein said logical sub-component of said genetic sequence is a member selected from the group consisting of restriction enzyme sites, endopeptidase sites, major grooves, minor groves, beta-sheet, alpha helices, ORFs, 5' UTRs, 3' UTRs, nbosome binding sites, glycosylation sites, signal peptide domains, intron-exon junctions, poly-A signals, transcription initiation sites, translation start sites, translation termination sites, methylation sites, zinc finger domains, modified amino acid sites, preproprotein-proprotein junctions, proprotein-protein junctions, transit peptide domains, SNPs, SSRs, RFLPs, insertion elements, transmembrane spanning regions and stem-loop structures.

12. The data processing system of claim 10, wherein said genetic sequence is a test sequence input into said memory from a gene or protein database.

13. The data processing system of claim 10, wherein said genetic sequence is a reference sequence.

14. The data processing system of claim 10, wherein said computer program is a genetic identification computer program.

15. The data processing system of claim 10, wherein said genetic sequence is: (i) a polynucieotide of at least 1800 contiguous nucleotides in length with at least 95% sequence identity to the polynucleotide sequence of SEQ ID NO:1, or (ii) a polypeptide of at least 600 contiguous amino acids in length with at least 95% sequence identity to the polypeptide sequence of SEQ ID NO:2.

Details for Patent 6,879,916

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Pioneer Hi-Bred International, Inc. (Des Moines, IA) 2019-07-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Pioneer Hi-Bred International, Inc. (Des Moines, IA) 2019-07-09 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Pioneer Hi-Bred International, Inc. (Des Moines, IA) 2019-07-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKesson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.